Low 30-Day Mortality After Atrial Fibrillation Ablation: Results From the Netherlands Heart Registration

Daniel Mol, Michelle D. van der Stoel, Jippe C. Balt, Rohit E. Bhagwandien, Yuri Blaauw, Pascal F.H.M. van Dessel, Vincent J.H.M. van Driel, Antoine H.G. Driessen, Arif Elvan, Rutger J. Hassink, Michiel J.B. Kemme, Karin Kraaier, Wichert J. Kuijt, Justin G.L.M. Luermans, Pepijn H. van der Voort, Sjoerd W. Westra, Joris R. de Groot, Jonas S.S.G. de Jong

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)1616-1618
Number of pages3
JournalCanadian Journal of Cardiology
Volume38
Issue number10
Early online date13 Jun 2022
DOIs
Publication statusPublished - 1 Oct 2022

Bibliographical note

Funding Information:
D. Mol reports speaker/consultancy fee from Abbott. Y. Blaauw is a proctor for Boston Scientific, Abbott, and Medtronic, and received research grants from Medtronic and Atricure . J.G.L.M Luermans reports grants from Biotronik , and a consultancy agreement with Medtronic, outside the submitted work. J.R. de Groot reports research grants to his institution from Atricure , Abbott , Boston Scientific , and Medtronic , personal fees from Atricure, Bayer, Daiichi Sankyo, Servier, Johnson & Johnson, Novartis, and Medtronic, outside the submitted work. J.C. Balt reports consultancy fee to his institution from Abbott. J.S.S.G. de Jong reports consultancy fees from Medtronic and speaker fees from Daiichi-Sankyo and Bayer, outside the submitted work. The remaining authors have no conflicts of interest to disclose.

Funding Information:
Joris R. de Groot and Jonas S.S.G. de Jong contributed equally to this work. None. D. Mol reports speaker/consultancy fee from Abbott. Y. Blaauw is a proctor for Boston Scientific, Abbott, and Medtronic, and received research grants from Medtronic and Atricure. J.G.L.M Luermans reports grants from Biotronik, and a consultancy agreement with Medtronic, outside the submitted work. J.R. de Groot reports research grants to his institution from Atricure, Abbott, Boston Scientific, and Medtronic, personal fees from Atricure, Bayer, Daiichi Sankyo, Servier, Johnson & Johnson, Novartis, and Medtronic, outside the submitted work. J.C. Balt reports consultancy fee to his institution from Abbott. J.S.S.G. de Jong reports consultancy fees from Medtronic and speaker fees from Daiichi-Sankyo and Bayer, outside the submitted work. The remaining authors have no conflicts of interest to disclose.

Cite this